CGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
COGNITION THERAPEUTICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.73−0.00 (-0.33%)
Close on Oct 19, 2026
- Market cap
- $65.92M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Cognition Therapeutics has not reported a dividend
No dividend per share appears in Cognition Therapeutics's annual filings since fiscal 2019.